High purity semaglutide is an analytical-grade synthetic GLP-1 receptor agonist engineered specifically for in vitro and preclinical laboratory research. Manufactured under strict quality systems in the United States, PX1 Research provides verified, lyophilized semaglutide featuring comprehensive lot-specific COAs, RP-HPLC purity exceeding 99%, and validated sub-0.01 EU/mg endotoxin levels.
High purity semaglutide is an analytical-grade synthetic GLP-1 receptor agonist engineered specifically for in vitro and preclinical laboratory research. Manufactured under strict quality systems in the United States, PX1 Research provides verified, lyophilized semaglutide featuring comprehensive lot-specific COAs, RP-HPLC purity exceeding 99%, and validated sub-0.01 EU/mg endotoxin levels.
High purity semaglutide is a synthesized 31-amino acid peptide analog of human glucagon-like peptide-1 (GLP-1) engineered exclusively for laboratory research use. It features a specific sequence modification replacing alanine with alpha-aminobutyric acid (Aib) at position 8, alongside a C18 fatty diacid side chain attached via a glutamic acid spacer at position 26. This precise structural architecture yields a high-affinity, long-acting GLP-1 receptor agonist optimized for analytical assays and cellular studies.
In experimental settings, raw material purity directly dictates data reproducibility and assay accuracy. Substandard or technical-grade peptide preparations frequently contain synthesis truncated sequences, residual trifluoroacetic acid (TFA), organic solvents, and heavy metals. PX1 Research delivers high purity semaglutide that undergoes rigorous purification steps to eliminate these impurities, ensuring that observed cellular responses are attributable solely to the active peptide target.
The molecular chemical formula of semaglutide is C187H291N45O59, with a calculated monoisotopic molecular weight of 4113.58 Da. The substitution of 2-aminoisobutyric acid (Aib) at position 8 confers substantial steric resistance against degradation by the enzyme dipeptidyl peptidase-IV (DPP-IV). This enzymatic resistance extends the functional biological half-life of the peptide in preclinical plasma models compared to native human GLP-1.
In addition to DPP-IV resistance, the acylation at Lys26 with a hydrophobic C18 fatty diacid moiety promotes non-covalent, reversible binding to serum albumin in culture media or animal serum models. This albumin interaction delays renal clearance and buffers peak concentration spikes, providing a sustained binding kinetic profile at the GLP-1 receptor (GLP-1R) during extended cell incubation or tissue culture experiments.
In vitro data indicate that high purity semaglutide acts as a potent agonist at human, primate, and rodent GLP-1 receptors. Binding assays demonstrate nanomolar affinity ($EC_{50}$ typically ranging between 0.01 nM and 0.1 nM depending on the cell line and signal transduction reporter assay utilized). Upon binding to the G-protein coupled GLP-1 receptor, semaglutide stimulates membrane-bound adenylate cyclase, triggering intracellular cyclic adenosine monophosphate (cAMP) accumulation.
Preclinical studies suggest that this elevation in cAMP activates protein kinase A (PKA) and exchange proteins directly activated by cAMP (EPAC), leading to downstream exocytosis of insulin-containing granules in isolated pancreatic beta-cell models. Beyond pancreatic endocrine pathways, researchers utilize semaglutide to study central nervous system satiety signaling, neuronal metabolism, neuroprotective pathways in neurodegenerative models, and gastrointestinal motility kinetics in animal studies.
To qualify as high purity research material, semaglutide must undergo rigorous characterization using validated analytical methodologies. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary quantitative method for determining chemical purity percentage. High-resolution RP-HPLC separates the main peptide peak from closely eluting synthesis impurities, such as D-amino acid diastereomers, deletion sequences, and beta-alanine insertion products.
Complementing chromatographic analysis, electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry is performed to confirm precise molecular mass. PX1 Research subjects every production lot to independent testing in an ISO 17025 accredited laboratory. Researchers can access fully detailed analytical reports in our centralized research library to verify batch consistency prior to experimental setup.
Bacterial endotoxins, primarily lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls, pose a significant confounding variable in cell culture and preclinical tissue studies. Presence of trace endotoxins can trigger unexpected toll-like receptor 4 (TLR4) activation, inflammatory cytokine release (such as TNF-alpha and IL-6), and cell cytotoxicity, contaminating experimental results.
PX1 Research enforces strict endotoxin control standards, testing every batch using the Chromogenic Limulus Amebocyte Lysate (LAL) assay according to USP <85> guidelines. Our high purity semaglutide is guaranteed to contain endotoxin levels below 0.01 EU/mg. This stringent threshold guarantees that cellular signaling pathways observed in vitro reflect native receptor activation rather than innate immune activation induced by bacterial contaminants.
When evaluating metabolic and incretin signaling pathways, researchers frequently compare single-agonist peptides with multi-receptor agonists. Single-target GLP-1 receptor agonists like semaglutide and liraglutide provide isolated data on GLP-1R signaling without confounding crosstalk from adjacent metabolic receptors.
In contrast, dual-agonist compounds such as tirzepatide engage both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, while triple-agonist analogs like retatrutide concurrently target GLP-1, GIP, and glucagon (GCGR) receptors. For a comprehensive breakdown of receptor affinity differences and cross-pathway signaling mechanisms, review our comparative analysis on tirzepatide vs semaglutide preclinical mechanisms.
High purity semaglutide is supplied as a lyophilized (freeze-dried) sterile cake or powder to maximize solid-state molecular stability. Reconstitution must be performed under aseptic laboratory conditions inside a laminar flow biosafety cabinet. Depending on the intended experimental protocol, common aqueous solvents include sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or specialized cell culture media.
When reconstituting lyophilized peptides, liquid should be allowed to run gently down the inner glass wall of the vial rather than sprayed directly onto the peptide cake. The vial should be gently swirled or rolled between the palms until completely dissolved. Agitation via vigorous vortexing or rapid mechanical shaking must be strictly avoided, as shear forces can induce peptide aggregation, denaturation, or surface adsorption. For exact molarity calculations and dilution protocols, refer to our peptide reconstitution calculator guide.
In its original lyophilized state, high purity semaglutide exhibits superior long-term stability when stored at -20°C to -80°C in a desiccated environment protected from light exposure. Avoid ambient humidity ingress, as moisture speeds up hydrolysis and acylation cleavage over extended storage periods.
Once reconstituted into aqueous solution, peptide stability decreases over time. Reconstituted aliquots should be stored at 2°C to 8°C for short-term use (typically up to 14 days) or flash-frozen in single-use working aliquots at -80°C for long-term storage. Repeated freeze-thaw cycles must be rigorously avoided, as freeze-induced concentration gradients and ice crystal formation can break down secondary peptide structures.
Selecting a reliable research peptide supplier requires verification of manufacturing transparency, batch-to-batch consistency, and rigorous analytical oversight. PX1 Research synthesizes all compounds in state-of-the-art, USA-based facilities operating under GMP-compliant quality management systems. Every step—from automated solid-phase peptide synthesis (SPPS) to final freeze-drying—is closely monitored.
We maintain fully traceable batch production records and provide lot-matched certificates of analysis (COA) for every shipment. Institutional buyers and university laboratories seeking large-scale or continuous compound supply can establish dedicated institutional accounts through our wholesale lab accounts portal, ensuring predictable lead times and verified purity across extended research timelines.
PX1 Research simplifies compound procurement for qualified academic, government, and private biotechnology research entities. Orders ship directly from our domestic fulfillment infrastructure located in California and Arizona, ensuring minimal transit times and maintained cold-chain integrity when temperature-sensitive shipping is required.
Explore our comprehensive index of research compounds within our all research peptides catalog, or review specialized metabolic pathways within our dedicated collection of GLP-1 receptor agonists. All products supplied by PX1 Research are strictly designated for in vitro diagnostic testing, chemical synthesis, and preclinical animal research.
What defines high purity semaglutide for laboratory use?
High purity semaglutide is defined as synthetic peptide material achieving equal to or greater than 99% chromatographic purity via RP-HPLC, verified by mass spectrometry (ESI-MS/MALDI-TOF), with validated sub-0.01 EU/mg bacterial endotoxin levels and complete absence of residual synthesis solvents.
How is the purity of PX1 Research semaglutide verified?
Every lot of semaglutide manufactured by PX1 Research undergoes third-party analytical testing at an independent ISO 17025 accredited laboratory. Verification includes RP-HPLC for purity percentage, Mass Spectrometry for sequence identity/molecular mass, and Chromogenic LAL testing for endotoxin levels.
What solvent should be used to reconstitute lyophilized semaglutide?
Common laboratory solvents include sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4). Choice of solvent depends on the sensitivity of the target cellular or animal model.
What is the molecular weight and formula of semaglutide?
Semaglutide has a molecular formula of C187H291N45O59 and a theoretical monoisotopic molecular mass of 4113.58 Da.
What is the recommended storage temperature for lyophilized semaglutide?
Lyophilized semaglutide powder should be stored at -20°C or -80°C in a dry container protected from light. Reconstituted liquid solutions should be stored at 2°C to 8°C for short-term use or flash-frozen at -80°C in single-use aliquots.
Why is endotoxin testing critical for semaglutide research?
Endotoxins (LPS) cause non-specific activation of toll-like receptor 4 (TLR4), triggering inflammatory cascades in cell cultures and tissue assays. Sub-0.01 EU/mg endotoxin testing ensures experimental observations stem exclusively from GLP-1 receptor binding.
How does semaglutide differ structurally from native GLP-1?
Semaglutide replaces alanine with alpha-aminobutyric acid at position 8 to prevent DPP-IV enzyme degradation and attaches a C18 fatty diacid side chain at Lys26 via a glutamic acid spacer to facilitate reversible albumin binding.
Can PX1 Research supply high purity semaglutide in bulk quantities for institutions?
Yes, PX1 Research provides institutional accounts and bulk procurement options for research laboratories, university facilities, and corporate R&D divisions through our wholesale program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.